APA (7th ed.) Citation

McBane, R. D., Wysokinski, W. E., Le‐Rademacher, J. G., Zemla, T., Ashrani, A., Tafur, A., . . . Loprinzi, C. L. (2020). Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial. Journal of thrombosis and haemostasis, 18(2), 411-421. https://doi.org/10.1111/jth.14662

Chicago Style (17th ed.) Citation

McBane, Robert D., et al. "Apixaban and Dalteparin in Active Malignancy‐associated Venous Thromboembolism: The ADAM VTE Trial." Journal of Thrombosis and Haemostasis 18, no. 2 (2020): 411-421. https://doi.org/10.1111/jth.14662.

MLA (9th ed.) Citation

McBane, Robert D., et al. "Apixaban and Dalteparin in Active Malignancy‐associated Venous Thromboembolism: The ADAM VTE Trial." Journal of Thrombosis and Haemostasis, vol. 18, no. 2, 2020, pp. 411-421, https://doi.org/10.1111/jth.14662.